Silvercrest Asset Management Group LLC Vertex Pharmaceuticals Inc Transaction History
Silvercrest Asset Management Group LLC
- $14.3 Billion
- Q3 2024
A detailed history of Silvercrest Asset Management Group LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Silvercrest Asset Management Group LLC holds 13,938 shares of VRTX stock, worth $5.72 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
13,938
Previous 13,759
1.3%
Holding current value
$5.72 Million
Previous $6.45 Million
0.51%
% of portfolio
0.05%
Previous 0.05%
Shares
23 transactions
Others Institutions Holding VRTX
# of Institutions
1,724Shares Held
221MCall Options Held
1.58MPut Options Held
1.36M-
Capital World Investors Los Angeles, CA26.8MShares$11 Billion1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.2MShares$9.51 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$8.75 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.8MShares$4.85 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA9MShares$3.7 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $105B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...